Patient release after Lu-177 DOTATATE and Lu-177 PSMA 617 therapies

被引：0
作者：
Mair, C. [1 ]
Warwitz, B. [1 ]
Buxbaum, S. [1 ]
Virgolini, I. J. [1 ]
机构：
[1] LKH Univ Kliniken Innsbruck, Univ Klin Nukl Med, Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0057
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [31] Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment
    Kibar, A.
    Ince, B.
    Nazari, A.
    Toplutas, K. N.
    Bilgic, S.
    Asa, S.
    Besli, R. L. Uslu
    Sager, M. S.
    Sayman, H. B.
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S470 - S470
  • [32] Radiation Dosimetry Aspects of Lu-177
    Lassmann, Michael
    Eberlein, Uta
    CURRENT RADIOPHARMACEUTICALS, 2015, 8 (02) : 139 - 144
  • [33] Optimisation of Lu-177 therapy administration
    Fernandez, R.
    Rai, S.
    Perry, A.
    Johnson, J.
    Croasdale, P.
    Eftychiou, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S661 - S662
  • [34] Lu-177 DOTATATE dosimetry for neuroendocrine tumor: single center experience
    Said, M. A.
    Masud, M. A.
    Zaini, M. Z.
    Salleh, R. A.
    Lee, B. N.
    Zainon, R.
    10TH INTERNATIONAL SEMINAR ON MEDICAL PHYSICS & 1ST AMDI INTERNATIONAL ONCOLOGY SYMPOSIUM, 2017, 851
  • [35] Prediction of resistance to PSMA-617 Lu-177 by assessment of circulating tumor DNA biomarkers
    Sartor, O.
    Ledet, E.
    Huang, M.
    Schwartz, J.
    Lieberman, A.
    Lewis, B.
    Layton, J.
    Jang, A.
    Pocha, O.
    Lanka, S.
    Hawkins, M.
    Harris, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S153 - S153
  • [36] Comparative evaluation of carrier added and non carrier added Lu-177 for preparation of therapeutic doses of Lu-177 radiopharmaceuticals
    Bhusari, P.
    Shukla, J.
    Singh, H.
    Sood, A.
    Mittal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S688 - S688
  • [37] Consequences of Meta-Stable Lu-177m Admixture in Lu-177 for Patient Dosimetry
    Konijnenberg, Mark W.
    CURRENT RADIOPHARMACEUTICALS, 2015, 8 (02) : 145 - 149
  • [38] Radiation Safety Challenges in Lu-177 PSMA: A Technologist's Prospective
    Webb, Chelsea
    Frye, Sarah
    Muzaffar, Razi
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Comparative Dosimetric Evaluation on the course of PRRT using non carrier added LU-177 DOTATATE (i.a., i.v), non carrier added LU-177 DOTATOC (i.v.) and carrier added LU-177 DOTATATE (i.v.)
    Paphiti, M.
    McCready, R. V.
    Dimitriadi, E. Z.
    Limouris, G. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S190 - S191
  • [40] NEW HOPE FOR METASTATIC PROSTATE CANCER TREATMENT: LU-177 PSMA
    James, D.
    Alchin, S.
    Batley, S.
    Muchirahondo, C.
    Sharp, C.
    Sipowicz, S.
    Watson, T.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 31 - 31
12345